CD8A and leukemia: Next, we determined the ability of splenic Tregs population, sorted from control and TCL1 leukemia-bearing B6 FoxP3EGFP mice to inhibit CD8+ T cell proliferation in an antigen unspecific test, where T cells were activated via anti-CD3 and anti-CD28 antibodies.